SCHOLAR ROCK HOLDING CORPORATION Letters of Credit Outstanding, Amount
SCHOLAR ROCK HOLDING CORPORATION (SRRK) had Letters of Credit Outstanding, Amount of $2.50 million as of 2022-12-31, per its 10-K filed 2023-03-07.
Financial Statements › Notes › Other Liabilities
us-gaap:LettersOfCreditOutstandingAmount · last filed 2026-08-06
- 2022-12-31: Letters of Credit Outstanding, Amount $2.50M.
- 2021-12-31: Letters of Credit Outstanding, Amount $2.50M.
- 2020-12-31: Letters of Credit Outstanding, Amount $2.50M.
- 2019-12-31: Letters of Credit Outstanding, Amount $2.50M.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2022-12-31 | $2.50M 10-K · filed 2023-03-07 |
| 2021-12-31 | $2.50M 10-K · filed 2023-03-07 |
| 2020-12-31 | $2.50M 10-K · filed 2021-03-09 |
| 2019-12-31 | $2.50M 10-K · filed 2020-03-12 |
| 2019-11-30 | $2.30M 10-Q · filed 2026-08-06 |
| 2018-12-31 | $200.00K 10-K · filed 2019-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |